Keen Vision Acquisition Corp.
Liquidated 2026-09-30- CIK 1889983
- KVAC
- IPO 2023-07-25
- $13.4M trust
- 109 filings
- IPO Size
- $150M
- raised at the IPO
- Trust
- $13.4M
- as of 2026-06-30
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2023
- year it listed
Filings, by quarter
109 filings over 15 quarters; violet bars carry a milestone
- 23 Q1: 5 filings
- 23 Q2: 6 filings
- 23 Q3: 18 filings
- 23 Q4: 1 filing
- 24 Q1: 6 filings
- 24 Q2: 2 filings
- 24 Q3: 4 filings
- 24 Q4: 18 filings
- 25 Q1: 6 filings
- 25 Q2: 9 filings
- 25 Q3: 8 filings
- 25 Q4: 7 filings
- 26 Q1: 8 filings
- 26 Q2: 5 filings
- 26 Q3: 6 filings
- S-1 filed 23 Q1
- IPO 23 Q3
- Liquidated 26 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Keen Vision Acquisition Corporation is a blank-check company seeking to combine with a business. It intends to focus on biotechnology, consumer goods, or agriculture, evaluating opportunities based on sustainability and ESG imperatives.
Investment Focus
Biopharmaceuticals, Consumer, Agriculture
Key Information
As the filings state it
- IPO Date
- 2023-07-25
- Total Redemptions
- $155M
- SIC
- 6770
- Failed Date
- 2026-09-30
- SPAC Ticker
- KVAC
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The founders, Kenneth Wong and Jason Wong, bring over 55 years of combined experience across entrepreneurship, operations, private equity, de-SPACs, and corporate finance. Kenneth Wong founded Keen Vision Capital, a single-family office focused on private equity; Jason Wong has decades of private equity experience and a track record with SPACs.